BANGALORE, India and MONMOUTH JUNCTION, N.J., Nov. 3, 2014 /PRNewswire/ -- Biocon Ltd (BSE code: 532523, NSE: BIOCON), Asia's premier biopharmaceuticals company, and U.S.-based CytoSorbents Corporation (CTSO) announced today that they have expanded ... Noodls, 6 days ago
BIOCON : Expands its Strategic Partnership with CytoSorbents for CytoSorb® to Treat SIRS and Cardiac Surgery Patients - 4 Traders, 1 week ago
Biocon gets exclusive rights to market CytoSorbents drug - Hindu Business Line, 2 weeks ago
Selangor -The Malaysian diabetic community's access to a bigger portfolio of safe, affordable and quality treatment options received a boost with the introduction of CCM- Biocon's recombinant human insulin; INSUGEN® in Malaysia. INSUGEN® is ...Noodls, 1 week ago CCM CHEMICAL OF MALAYSIA BHD : -BIOCON Introduces Insugen® And Insupen® 4 Traders, 1 week ago
Biocon Ltd, a biopharmaceutical company, and CytoSorbents Corporation have expanded the scope of their strategic partnership for CytoSorbents' CytoSorb cytokine reduction therapy to treat patients experiencing severe whole body inflammation, often ...Individual.com, 1 week ago Biocon expands partnership with US-based CytoSorbents Business Standard India, 2 weeks ago Biocon expands pact with CytoSorbents to treat SIRS & cardiac surgery patients PharmaBiz, 2 weeks ago
Biocon, a publicly held biotechnology company, and US-based CytoSorbents Corporation on Monday announced that they have expanded the scope of their strategic partnership for CytoSorbents CytoSorb, a critical care drug. Biocon had partnered with ...Business Standard India, 2 weeks ago
Twenty-six feature and 15 non-features have been chosen for the prestigious Indian Panorama, an integral part of the International Film Festival of India (IFFI), to be held in Panaji from November 20. A still from Drishyam. (Photo Courtesy: ...Hindustan Times, 1 month ago
on your WebpageAdd Widget >Get your members hooked!